Suppr超能文献

糖尿病是慢性丙型肝炎患者发生肝硬化的重要危险因素。

Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.

机构信息

Department of Hepatology, The First Hospital of Jilin University, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.

Department of Neurology, The First Hospital of Jilin University, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.

出版信息

Sci Rep. 2017 Aug 22;7(1):9087. doi: 10.1038/s41598-017-09825-7.

Abstract

We explored the association between diabetes mellitus (DM) and the risk of hepatitis C virus (HCV)-related liver cirrhosis in Chinese patients with chronic hepatitis C (CHC). To examine the link between DM and liver cirrhosis, we conducted a case-control study of 210 Chinese CHC patients diagnosed with liver cirrhosis, comparing them to an age- and sex-matched control group of 431 CHC patients without liver cirrhosis. We conducted logistic regression analyses adjusting for demographic features and liver cirrhosis risk factors, and found that DM increased the risk of developing liver cirrhosis 2-fold [adjusted odds ratio (AOR), 2.132; 95% confidence interval (CI), 1.344-3.382]. Furthermore, the proportion of liver cirrhosis patients and CHC-only patients with elevated serum triglycerides (>1.8 mmol/L) were 5.2% and 17.4%, respectively, yielding an AOR of 0.264 (95% CI, 0.135-0.517). Multivariate analyses that stratified the risk of developing HCV-related liver cirrhosis in DM patients by gender revealed that the estimated AOR (95% CI) for males was 0.415 (0.178-0.969). In conclusion, DM was associated with an increased risk of developing liver cirrhosis in CHC patients in China. Furthermore, among patients diagnosed with both CHC and DM, females had an increased risk of liver cirrhosis development.

摘要

我们探讨了糖尿病(DM)与中国慢性丙型肝炎(CHC)患者丙型肝炎病毒(HCV)相关肝硬化风险之间的关联。为了研究 DM 与肝硬化之间的联系,我们对 210 名中国 CHC 患者进行了病例对照研究,这些患者被诊断为肝硬化,并将其与 431 名年龄和性别匹配的无肝硬化的 CHC 患者对照组进行了比较。我们进行了逻辑回归分析,调整了人口统计学特征和肝硬化危险因素,发现 DM 使发生肝硬化的风险增加了 2 倍[调整后的优势比(AOR),2.132;95%置信区间(CI),1.344-3.382]。此外,血清甘油三酯升高(>1.8mmol/L)的肝硬化患者和仅 CHC 患者的比例分别为 5.2%和 17.4%,AOR 为 0.264(95%CI,0.135-0.517)。对 DM 患者按性别分层的 HCV 相关肝硬化发病风险的多变量分析表明,男性的估计 AOR(95%CI)为 0.415(0.178-0.969)。总之,DM 与中国 CHC 患者发生肝硬化的风险增加有关。此外,在同时诊断出 CHC 和 DM 的患者中,女性发生肝硬化的风险增加。

相似文献

引用本文的文献

5
Metabolic complications of hepatitis C virus infection.丙型肝炎病毒感染的代谢并发症。
World J Gastroenterol. 2021 Apr 7;27(13):1267-1282. doi: 10.3748/wjg.v27.i13.1267.
9
Metabolic Syndrome in HIV/HCV Co-infected Patients.HIV/HCV 合并感染患者的代谢综合征
Curr Treat Options Infect Dis. 2019 Dec;11(4):351-371. doi: 10.1007/s40506-019-00207-3. Epub 2019 Dec 2.

本文引用的文献

6
Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne.糖尿病与非酒精性脂肪性肝病:阿里阿德涅之线
Minerva Endocrinol. 2017 Jun;42(2):109-121. doi: 10.23736/S0391-1977.16.02562-1. Epub 2016 Dec 16.
10
Metabolic alterations and hepatitis C: From bench to bedside.代谢改变与丙型肝炎:从实验室到临床
World J Gastroenterol. 2016 Jan 28;22(4):1461-76. doi: 10.3748/wjg.v22.i4.1461.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验